Corbus Pharmaceuticals Holdings (CRBP) EBIT Growth (5y) (2018 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) EBIT Growth (5y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 136.49 Mn | 108.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 15.25% |
| Jun 30, 2025 | 12.87% |
| Mar 31, 2025 | 7.93% |
| Dec 31, 2024 | 15.61% |
| Sep 30, 2024 | 15.73% |
| Jun 30, 2024 | -1.27% |
| Mar 31, 2024 | 15.31% |
| Dec 31, 2023 | 10.50% |
| Sep 30, 2023 | 8.63% |
| Jun 30, 2023 | 7.95% |
| Mar 31, 2023 | -7.83% |
| Dec 31, 2022 | 0.12% |
| Sep 30, 2022 | -3.30% |
| Jun 30, 2022 | -11.10% |
| Mar 31, 2022 | -2.71% |
| Sep 30, 2021 | -21.07% |
| Jun 30, 2021 | -31.85% |
| Mar 31, 2021 | -39.79% |
| Dec 31, 2020 | -52.77% |
| Sep 30, 2020 | -72.03% |